Egyptian evidence-based consensus on clinical practice recommendations for the management of Kawasaki disease
-
Published:2023-04-10
Issue:1
Volume:50
Page:
-
ISSN:2090-3235
-
Container-title:Egyptian Rheumatology and Rehabilitation
-
language:en
-
Short-container-title:Egypt Rheumatol Rehabil
Author:
El Miedany YasserORCID, Salah SamiaORCID, Lotfy Hala M.ORCID, Abu-Zaid Mohammed HassanORCID, Mohamed Sally S.ORCID, Maher Sheren EsamORCID, El Gaafary MahaORCID, Abdulhady HalaORCID, Farag YomnaORCID, Eissa MervatORCID, Radwan AhmedORCID, Medhat Basma M.ORCID, El Mikkawy Dalia M. E.ORCID, Hassan Waleed A.ORCID, Mosa Doaa MosadORCID, El Deriny GhadaORCID, Mortada MohamedORCID, Osman Naglaa S.ORCID, Fouad Nermeen AhmedORCID, Amer Youmna AhmedORCID, Nasef Samah IsmailORCID, Abushady HendORCID, Galal SalwaORCID, El-Latif Eiman AbdORCID, Maria DinaORCID, Shabana Ahmed H.ORCID, Tabra Samar AbdAlhamedORCID
Abstract
Abstract
Background
Kawasaki disease (KD) is an acute, self-limited febrile disease of unidentified cause that mostly affects children less than 5 years of age. This work aimed to provide an appropriate Egyptian evidence-based consensus on clinical practice recommendations for the management of Kawasaki disease. The main objective of this study, which employed the Delphi method, was to reach a consensus among experts on a treat-to-target management approach for KD.
Results
The expert panel was confined to an online survey (n=26), and all the expert completed the three rounds. At the conclusion of round 3, a total of 17 recommendation items were gathered, which were divided into two sections. The range of respondents (ranks 7–9) who agreed with the recommendations was 92.3 to 100%. All 17 clinical standards identified by the scientific committee were written in the same way. There have been algorithms proposed for managing various KD conditions.
Conclusion
The developed evidence-based consensus recommendations for the diagnosis and management of KD represent an up-to-date document that focuses on clinical management questions which are generally posed to health care professionals involved in the management of KD. This guideline was developed considering experience with and availability of treatment and diagnostic options in Egypt.
Publisher
Springer Science and Business Media LLC
Subject
General Earth and Planetary Sciences,General Environmental Science,Industrial and Manufacturing Engineering,Materials Science (miscellaneous),Business and International Management
Reference26 articles.
1. Burns JCM (2002) Commentary: translation of Dr. Tomisaku Kawasaki’s original report of fifty patients in 1967. Pediatr Infect Dis J 21(11):993–995 2. Burns JC, Kushner HI, Bastian JF, Shike H, Shimizu C, Matsubara T et al (2000) Kawasaki disease: a brief history. Pediatrics 106:E27 3. Hoste L, Van Paemel R, Haerynck F (2021) Multisystem inflammatory syndrome in children related to COVID-19: a systematic review. Eur J Pediatr. 180(7):2019–2034. https://doi.org/10.1007/s00431-021-03993-5 4. Attia TH, Morsy SM, Hassan BA, Ali ASA (2017) Kawasaki disease among Egyptian children: a case series. Glob Cardiol Sci Pract 2017(3):e201725 5. Agha HM, Hamza HS (2017) Incomplete Kawasaki disease in Egypt. Glob Cardiol Sci Pract 2017(3):e201724
|
|